Expanding Radiopharmaceuticals Beyond Established Indications Through Engineered Scaffold Proteins

Name: Expanding Radiopharmaceuticals Beyond Established Indications Through Engineered Scaffold Proteins
Start: 2026-12-03T14:00
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 3 December 2026 · 14:00

Expanding Radiopharmaceuticals Beyond Established Indications Through Engineered Scaffold Proteins was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 3 December 2026 in London, with 1 speaker on record.

Speakers

Fredrik Frejd — Speaker Chief Scientific Officer, Affibody AB